A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models

Published:2020-11 Issue: Volume:90-91 Page:74-83
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Ferguson Simon,Wuest Melinda,Richter Susan,Bergman Cody,Dufour Jennifer,Krys Daniel,Simone Jennifer,Jans Hans-Sonke,Riauka Terence,Wuest Frank

Funder

Dianne and Irving Kipnes Foundation

National Science and Engineering Research Council of Canada

Alberta Innovates Health Solutions

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference53 articles.

1. Radiolabeled peptides: valuable tools for the detection and treatment of cancer;Fani;Theranostics,2012

2. Radiolabeled peptides: current and new perspectives;Opalinska;Q J Nucl Med Mol Imaging,2017

3. An overview of bioactive peptides for in vivo imaging and therapy in human diseases;Tornesello;Mini Rev Med Chem,2017

4. Radiopeptides for imaging and therapy: a radiant future;Chatalic;J Nucl Med,2015

5. Theranostics: combining imaging and therapy;Kelkar;Bioconjug Chem,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

2. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer;Annals of Medicine;2024-03-05

3. Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review;Seminars in Nuclear Medicine;2024-03

4. Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers;Cancer Imaging;2024-01-26

5. Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling;RSC Medicinal Chemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3